Figure 3.
PET2-based PFS analysis comparing treatment intention. Kaplan-Meier PFS analysis assessed from date of PET2 scan comparing chemotherapy-alone (chemo) vs CMT based on PET2 response. (A) PET2-negative (DS 1-2). (B) PET2-negative (DS 1-3). (C) PET2-positive (DS ≥3). (D) PET2-positive (DS ≥4).

PET2-based PFS analysis comparing treatment intention. Kaplan-Meier PFS analysis assessed from date of PET2 scan comparing chemotherapy-alone (chemo) vs CMT based on PET2 response. (A) PET2-negative (DS 1-2). (B) PET2-negative (DS 1-3). (C) PET2-positive (DS ≥3). (D) PET2-positive (DS ≥4).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal